Inhibitors of serine proteases, particularly hepatitis C virus NS3-NS4 protease
Details for Australian Patent Application No. 2003223602 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/371,846 11.04.02 US
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003223602
13 May 2010 Application Accepted
Published as AU-B-2003223602
27 May 2010 Corrigenda
Applications Accepted - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2003223602, under INID (72) correct the coinventor to read Perni, Robert B.
9 September 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003223603-LAMBDA SENSING WITH A FUEL CELL STACK
2003223601-ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser